Sperling Prostate Center

Category: Active Surveillance

Statins and Prostate Cancer: An Update

Last December I posted a blog entry on the possibility that statins, a class of cholesterol-lowering drugs, can reduce the risk of developing aggressive prostate cancer (PCa). If you’re interested, I summarized the relationship between how statins control cholesterol and scientific theories about the connection with PCa; you can read it at https://sperlingprostatecenter.com/statins-prostate-cancer/. I try keep reading

What Happens When Prostate Biopsies Are Negative?

The annual American Urological Society meeting (AUA 2015, May 15-19) has more presentations than ever on multiparametric MRI detection of prostate cancer, MRI targeted biopsies, MRI/ultrasound fusion, and MRI-guided focal therapies. The urologic world is sitting up and taking notice as advanced imaging is changing the prostate cancer landscape. I will be sharing selected presentations keep reading

The Impact of the Recommendation Against PSA Screening

In 2012, the U.S. Preventive Services Task Force (USPSTF) issued a recommendation against routine PSA screening for otherwise healthy men. Almost immediately, prostate cancer support organizations and hundreds of clinical professionals raised an outcry. While acknowledging that the non-prostate cancer specific blood test often led to over-detection and over-treatment of indolent prostate cancer, countless lives keep reading

Understanding the “Watchful Waiting” Approach in Prostate Cancer Treatment

The American Cancer Society estimated that about 1 in every 6 males will be diagnosed with prostate cancer in their lifetimes. Here at our prostate cancer treatment practice, surgery is not recommended right away. Dr. Sperling offers several methods to treat prostate tumors minus the surgical approach. Active Surveillance in Prostate Cancer Treatment One of keep reading
WordPress Image Lightbox